Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Amortizatization of Intangibles: 2024

Historic Amortizatization of Intangibles for Zevra Therapeutics (ZVRA) over the last 1 years, with Dec 2024 value amounting to $890,000.

  • Zevra Therapeutics' Amortizatization of Intangibles was N/A to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $890,000 for FY2024, which is N/A change from last year.
  • As of FY2024, Zevra Therapeutics' Amortizatization of Intangibles stood at $890,000.
  • In the past 5 years, Zevra Therapeutics' Amortizatization of Intangibles registered a high of $890,000 during FY2024, and its lowest value of $890,000 during FY2024.
  • Moreover, its 1-year median value for Amortizatization of Intangibles was $890,000 (2024), whereas its average is $890,000.